Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines.
Ujiie
H
H
Shimizu
T
T
Natsuga
K
K
Arita
K
K
Tomizawa
K
K
Shimizu
H
H
D000328:Adult; D002086:Butylscopolammonium Bromide / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015444:Exercise; D015738:Famotidine / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006358:Hot Temperature / Q000009:adverse effects; D006801:Humans; D006919:Hydroxyzine / Q000627:therapeutic use; D008297:Male; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use; D014581:Urticaria / Q000188:drug therapy* / Q000209:etiology
D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D018727:Muscarinic Antagonists; D010879:Piperazines; D002086:Butylscopolammonium Bromide; D006919:Hydroxyzine; D015738:Famotidine; C015408:oxatomide